A health intervention improves cognition in older adults at risk for Alzheimer’s Disease
Both HC and HE produced significant improvements in many cognitive paradigms among APOE4 non-carriers, though subjective cognitive decline was only improved in APOE4 non-carriers. More information is needed to dissect the impetus for the changes in cognition.
Authors
- Jordan M. Glenn (ORCID: https://orcid.org/0000-0002-2563-4291)
- Sally Paulson (ORCID: https://orcid.org/0000-0001-8411-5259)
- Anthony Campitelli (ORCID: https://orcid.org/0000-0001-9191-9263)
- Joshua L. Gills (ORCID: https://orcid.org/0000-0003-3321-4120)
- Megan Jones (ORCID: https://orcid.org/0000-0003-1023-310X)
- Michelle Gray (ORCID: https://orcid.org/0000-0001-5721-9087)
- Ray Urbina
Institutions
- St. Elizabeth Healthcare (US)
- Clinical Research Institute (US)
- Neurotrack Technologies (United States) (US)
- New York University (US)
- University of Arkansas at Fayetteville (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.089964
- Primary Topic
- Health, psychology, and well-being
- Type
- article
- Field-Weighted Citation Impact
- 0.00